Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080518304> ?p ?o ?g. }
- W3080518304 endingPage "2723" @default.
- W3080518304 startingPage "2723" @default.
- W3080518304 abstract "Globally, diabetes mellitus is a leading cause of kidney disease, with a critical percent of patients approaching end-stage kidney disease. In the current era, sodium-glucose co-transporter 2 inhibitors (SGLT2i) have emerged as phenomenal agents in halting the progression of kidney disease. Positive effects of SGLT2i are centered on multiple mechanisms, including glycosuric effects, tubule—glomerular feedback, antioxidant, anti-fibrotic, natriuretic, and reduction in cortical hypoxia, alteration in energy metabolism. Concurrently, multiple kidney and cardiovascular outcome studies have reported remarkable advantages of SGLT2i including mortality benefits. Additionally, the superiority of combination therapies (SGLT2I along with metformin/DDP-4 Inhibitors) in treatment-naïve diabetic patients is further looked into with potential signal towards glycemic and blood pressure control. Reported promising results initiate a gateway for future research targeting kidney outcomes with combination therapies as an initial approach. In the current paper, we summarize leading cardiovascular and kidney outcome trials in patients with type 2 diabetes, the role of SGLT2i in non-diabetic proteinuric kidney disease, and the potential mechanisms of action of SGLT2i with special focus on combination therapy as an initial therapeutic approach in treatment-naïve diabetic patients." @default.
- W3080518304 created "2020-09-01" @default.
- W3080518304 creator A5003808101 @default.
- W3080518304 creator A5021054946 @default.
- W3080518304 creator A5026421426 @default.
- W3080518304 creator A5038065088 @default.
- W3080518304 creator A5038578876 @default.
- W3080518304 creator A5049904132 @default.
- W3080518304 creator A5053087229 @default.
- W3080518304 creator A5074546182 @default.
- W3080518304 creator A5080120125 @default.
- W3080518304 creator A5089096365 @default.
- W3080518304 date "2020-08-24" @default.
- W3080518304 modified "2023-10-10" @default.
- W3080518304 title "SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease" @default.
- W3080518304 cites W1525396932 @default.
- W3080518304 cites W1898894592 @default.
- W3080518304 cites W1953840628 @default.
- W3080518304 cites W1974115114 @default.
- W3080518304 cites W1990025047 @default.
- W3080518304 cites W2019285763 @default.
- W3080518304 cites W2027545319 @default.
- W3080518304 cites W2030192134 @default.
- W3080518304 cites W2044102243 @default.
- W3080518304 cites W2045790951 @default.
- W3080518304 cites W2053394694 @default.
- W3080518304 cites W2056976690 @default.
- W3080518304 cites W2066246982 @default.
- W3080518304 cites W2085015828 @default.
- W3080518304 cites W2136503478 @default.
- W3080518304 cites W2142065502 @default.
- W3080518304 cites W2146264128 @default.
- W3080518304 cites W2152413054 @default.
- W3080518304 cites W2153839551 @default.
- W3080518304 cites W2153908199 @default.
- W3080518304 cites W2168450459 @default.
- W3080518304 cites W2171471305 @default.
- W3080518304 cites W2182718273 @default.
- W3080518304 cites W2231922283 @default.
- W3080518304 cites W2278329651 @default.
- W3080518304 cites W2424539745 @default.
- W3080518304 cites W2475261460 @default.
- W3080518304 cites W2492672367 @default.
- W3080518304 cites W2498901811 @default.
- W3080518304 cites W2506990877 @default.
- W3080518304 cites W2538443876 @default.
- W3080518304 cites W2550194700 @default.
- W3080518304 cites W2560643142 @default.
- W3080518304 cites W2564078202 @default.
- W3080518304 cites W2582603147 @default.
- W3080518304 cites W2583476095 @default.
- W3080518304 cites W2595201361 @default.
- W3080518304 cites W2602271880 @default.
- W3080518304 cites W2623313315 @default.
- W3080518304 cites W2626446274 @default.
- W3080518304 cites W2746113086 @default.
- W3080518304 cites W2749215350 @default.
- W3080518304 cites W2750589886 @default.
- W3080518304 cites W2765183832 @default.
- W3080518304 cites W2769932926 @default.
- W3080518304 cites W2776979473 @default.
- W3080518304 cites W2781483265 @default.
- W3080518304 cites W2782103987 @default.
- W3080518304 cites W2790286202 @default.
- W3080518304 cites W2791162071 @default.
- W3080518304 cites W2807239802 @default.
- W3080518304 cites W2807501871 @default.
- W3080518304 cites W2807732548 @default.
- W3080518304 cites W2808915250 @default.
- W3080518304 cites W2809595382 @default.
- W3080518304 cites W2809632141 @default.
- W3080518304 cites W2810892857 @default.
- W3080518304 cites W2884817413 @default.
- W3080518304 cites W2884961588 @default.
- W3080518304 cites W2886679183 @default.
- W3080518304 cites W2887280388 @default.
- W3080518304 cites W2887628755 @default.
- W3080518304 cites W2899540247 @default.
- W3080518304 cites W2899764361 @default.
- W3080518304 cites W2900413769 @default.
- W3080518304 cites W2901012416 @default.
- W3080518304 cites W2901351833 @default.
- W3080518304 cites W2907263162 @default.
- W3080518304 cites W2910145779 @default.
- W3080518304 cites W2911996337 @default.
- W3080518304 cites W2913123058 @default.
- W3080518304 cites W2915151824 @default.
- W3080518304 cites W2917112529 @default.
- W3080518304 cites W2917373968 @default.
- W3080518304 cites W2921178500 @default.
- W3080518304 cites W2921909972 @default.
- W3080518304 cites W2927285401 @default.
- W3080518304 cites W2939222610 @default.
- W3080518304 cites W2940024069 @default.
- W3080518304 cites W2944717765 @default.
- W3080518304 cites W2945272854 @default.
- W3080518304 cites W2947062659 @default.
- W3080518304 cites W2948520814 @default.